, Tracking Stock Market Picks
Enter Symbol:
Nxstage Medical, Inc. (NXTM) [hlAlert]

up 15.61 %

Nxstage Medical, Inc. (NXTM) rated Buy by ThinkEquity

Posted on: Friday,  Jul 20, 2012  8:26 AM ET by ThinkEquity

ThinkEquity rated Buy Nxstage Medical, Inc. (NASDAQ: NXTM) on 07/20/2012, when the stock price was $15.31. Since
then, Nxstage Medical, Inc. has gained 15.61% as of 01/26/2016's recent price of $17.70.
If you would have followed this ThinkEquity's recommendation on NXTM, you would have gained 15.61% of your investment in 1285 days.

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/20/2012 8:26 AM Buy
as of 12/31/2012
1 Week up  3.30 %
1 Month down  -6.40 %
3 Months down  -14.83 %
1 YTD down  -26.51 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy